Genmab — Juli 2015
-
Vil stadigvæk gerne vide hvad modtrækket mod bud vil være fra ATP og andre? Fordi drømmescenariet må være bud 1800kr. sælg som investor og genkøb ved afslag til 1000kr. men det afhænger af budstørrelse vs afslag og om de vil give et second bud for så er det dumt at have solgt med forventning om afslag.
-
Nogen der kender ejerandelen for disse major stakeholders? http://ir.genmab.com/ownership-profile.cfm
-
Genentech/Roche modellen var dramatisk nok: http://knowledge.wharton.upenn.edu/article/anatomy-of-a-merger-hostile-deals-become-friendly-in-the-end-right/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind